(Q45049371)

8 December 2017

title

Leukoregulin up-regulation of tumor cell sensitivity to natural killer and lymphokine-activated killer cell cytotoxicity (English)

1 reference

8 December 2017

P M Furbert-Harris

1

1 reference

8 December 2017

C H Evans

series ordinal

2

1 reference

8 December 2017

publication date

1 January 1989

1 reference

Cancer Immunology, Immunotherapy

8 December 2017

published in

1 reference

8 December 2017

volume

30

1 reference

8 December 2017

issue

2

1 reference

8 December 2017

page(s)

86-91

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01665958

8 December 2017

exact match

0 references

cites work

Human natural killer cells: biologic and pathologic aspects

1 reference

12 December 2020

Leukoregulin, a direct-acting anticancer immunological hormone that is distinct from lymphotoxin and interferon

1 reference

12 December 2020

Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis

1 reference

12 December 2020

Role of cytokines in the monocyte-mediated augmentation of human natural killer cell activity

1 reference

12 December 2020

Leukoregulin-induced translocation of protein kinase C activity in K562 cells

1 reference

12 December 2020

Inhibition of human natural killer activity by monolayers of primary cell cultures.

1 reference

12 December 2020

Natural cytotoxicity of human blood lymphocytes and monocytes and their cytotoxic factors: effect of interferon on target cell susceptibility

1 reference

12 December 2020

Monocyte-mediated augmentation of human natural killer cell activity: conditions, monocyte and effector cell characteristics

1 reference

12 December 2020

Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells

1 reference

12 December 2020

Integration and transcription of human papillomavirus type 16 and 18 sequences in cell lines derived from cervical carcinomas

1 reference

12 December 2020

Normal levels of lymphotoxin secretion by freshly isolated and refrigerated human peripheral blood lymphocytes

1 reference

12 December 2020

Characterization and modulation of human lymphokine (interleukin 2) activated killer cell induction.

1 reference

12 December 2020

Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines.

1 reference

12 December 2020

Inhibition of in vitro LAK generation by OK-432

1 reference

12 December 2020

Lymphotoxin enhances the susceptibility of neoplastic and preneoplastic cells to natural killer cell mediated destruction.

1 reference

12 December 2020

Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor alpha and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicity

1 reference

12 December 2020

Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF)

1 reference

12 December 2020

Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome

1 reference

12 December 2020

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

12 December 2020

Effects of systemic recombinant interleukin-2 on natural killer and lymphokine activated killer activity of human tumor infiltrating lymphocytes

1 reference

12 December 2020

Up- and down-regulation of human lymphokine (IL-2)-activated killer cell induction by monocytes, depending on their functional state.

1 reference

12 December 2020

The role of interleukin 1 (IL 1) in tumor-NK cell interactions: correction of defective NK cell activity in cancer patients by treating target cells with IL 1.

1 reference

12 December 2020

Cell-mediated cytotoxicity against virus-infected target cells in humans. I. Characterization of the effector lymphocyte

1 reference

12 December 2020

Inhibition of human natural killer cell activity by platelet-derived growth factor

1 reference

12 December 2020

Identification and separation by bacterial adherence of human lymphocytes that suppress natural cytotoxicity

1 reference

12 December 2020

Natural killer cells: their roles in defenses against disease

1 reference

12 December 2020

Leukoregulin-increased plasma membrane permeability and associated ionic fluxes.

1 reference

12 December 2020

IL-2- and IFN gamma-enhanced natural cytotoxic activity: analysis of the role of different lymphoid subsets and implications for activation routes

1 reference

12 December 2020

Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL 2) in collaboration with interferon-gamma (IFN-gamma).

1 reference

12 December 2020

Interleukin 4 (B cell stimulatory factor 1) can mediate the induction of lymphokine-activated killer cell activity directed against fresh tumor cells

1 reference

12 December 2020

Flow cytometric evaluation of leukoregulin as an intrinsic molecular mediator of natural killer lymphocyte cytotoxicity

1 reference

12 December 2020

Chromosome observations on three epithelial-cell cultures derived from carcinomas of the human cervix.

1 reference

12 December 2020

Regulation of human natural killer (NK) cell function: induction of killing of an NK-resistant renal carcinoma cell line.

1 reference

12 December 2020

Tumor necrosis factor-alpha enhances cytolytic activity of human natural killer cells

1 reference

12 December 2020

Effect of interleukin 2 on the inhibition of human natural killer activity by monolayer cells

1 reference

12 December 2020

Retinoblastoma: a primitive tumor with multipotential characteristics

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01665958

1 reference

Dimensions Publication ID

8 December 2017

1029617101

0 references

1 reference